Neurodegenerative Diseases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neurodegenerative Diseases stocks.

Neurodegenerative Diseases Stocks Recent News

Date Stock Title
May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
May 15 ABOS Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 15 ABOS Q1 2024 Acumen Pharmaceuticals Inc Earnings Call
May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
May 14 BIIB Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
May 14 ABOS Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript
May 14 NRSNW NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning
May 14 NRSN NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning
May 14 ABOS Acumen Pharmaceuticals GAAP EPS of -$0.25
Neurodegenerative Diseases

Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

Browse All Tags